Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin

Thank you Larry. This article is very new and fresh. Ait was accepted for publishing 29 August 2019!! And this report is now in press but available online. So great to read about their ongoing senolytic research. 

they continue to use only 100 mg dasatinib and this time they use 500 mg Q twice a day. Done for three days. 

I can't find what kind of Q they have used here but I guess it is quercetin phytosome. But that is only a guess. 

Once again Larry - Thank you for sharing and great work in finding this report so early.